Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivatives and their medical use

Details for Australian Patent Application No. 2007267176 (hide)

Owner Neurosearch A/S

Inventors Hansen, Henrik Bjork; Redrobe, John Paul; Dyhring, Tino; Loechel, Steven Charles; Christensen, Jeppe Kejser; Peters, Dan; Nielsen, Elsebet Ostergaard; Olsen, Gunnar M.; Timmermann, Daniel B.; Mikkelsen, Jens Damsgaard

Agent Davies Collison Cave

Pub. Number AU-A-2007267176

PCT Pub. Number WO2007/138039

Priority PA 2006 00730 30.05.06 DK; 60/809,023 30.05.06 US

Filing date 29 May 2007

Wipo publication date 6 December 2007

International Classifications

C07D 471/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

27 November 2008 PCT application entered the National Phase

  PCT publication WO2007/138039 Priority application(s): WO2007/138039

9 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007267177-Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivatives and their medical use

2007267175-Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use